Advisor Group Holdings, Inc. Tempest Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 25,722 shares of TPST stock, worth $174,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,722
Previous 25,378
1.36%
Holding current value
$174,395
Previous $21,000
1071.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TPST
# of Institutions
28Shares Held
2.04MCall Options Held
42.8KPut Options Held
72.9K-
Black Rock Inc. New York, NY550KShares$3.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA433KShares$2.94 Million0.0% of portfolio
-
Ubs Group Ag324KShares$2.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA298KShares$2.02 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA115KShares$776,7100.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $70.6M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...